Assessing Clinical Trial Experiences of Patients With Osteosarcoma
Clinical study participation has historically been heavily biased toward specific demographics.

Several people will be invited to enroll in this study so that it may collect a variety of data about osteosarcoma clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.

People with osteosarcoma who are invited to take part in medical research will benefit from the analysis of the data.
Osteosarcoma
Number of patients who decide to enroll in an osteosarcoma clinical trial, 3 months|Rate of patients who remain in osteosarcoma clinical trial to trial completion, 12 months
Clinical study participation has historically been heavily biased toward specific demographics.

Several people will be invited to enroll in this study so that it may collect a variety of data about osteosarcoma clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.

People with osteosarcoma who are invited to take part in medical research will benefit from the analysis of the data.